Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Helen Ross

Dr. Helen Ross

Associate Professor of Medicine

Dr. Helen Ross spends much of her time educating women about the continuing threat of lung cancer.

Get in touch
Jump to a Topic:

About Helen Ross

  • Pleural and Lung Cancer icon

    Pleural and Lung Cancer

  • Peritoneal Mesothelioma icon

    Peritoneal Mesothelioma

  • Research Excellence icon

    Excellence in Research

  • 20+ Years of Experience icon

    20+ Years of Experience

Ross is head of the Thoracic Malignancies Group at the Mayo Clinic in Arizona and often speaks on the latest multi-modality therapy to combat lung cancer – and the subtleties of the disease that are particular to women.

She also has a strong interest in other thoracic diseases like malignant mesothelioma and esophageal cancers. Lung cancer, though, is the most often discussed. Lung cancer is among the diseases caused by asbestos.

Focus on Lung Cancer

Ross was a featured speaker at the Mayo Clinic’s 2012 Living with Cancer Symposium. She directed a 2011 symposium entitled “Thoracic Oncology for the Non-Oncologist.” At both she spoke passionately about lung cancer.

“It is often a disease, and increasingly a disease, of young women with light or no smoking history,” she said. “Unfortunately, it’s often diagnosed late. Early symptoms are mistaken for other illnesses. And women with lung cancer have particular problems.”

Helen Ross M.D. Associate Professor of Medicine

“When most women think of cancer, if they do (think about it) at all, they think that breast cancer is the largest threat to their lives. But since the mid-1980s, lung cancer has been the leading cause of cancer deaths in women. Lung cancer kills more women than ovarian, breast and colon cancers combined. It affects more than 100,000 women every year.”

With more than 23 years experience in the medical field and affiliations with one of the nation’s leading hospitals, Ross is a prominent internist and medical oncologist. Highly regarded by both peers and patients, she was named one of America’s Top Doctors by Castle Connolly, indicating a combination of professionalism and medical skill.

The Mayo Clinic Hospital in Phoenix, where she spends much of her time, was ranked 26th of 5,200 hospitals rated by U.S. News and World Report.

In addition to her specialties in lung cancer and asbestos-related cancers like mesothelioma, Ross also specializes in chest wall tumors, esophageal cancers and immune system disorders. Her treatment approach often incorporates multimodal treatment, which combines two or more types of therapy.

Doctor talking to patients

Talk to a Doctor About Your Diagnosis

We can help you or a loved one get in contact with Dr. Ross and find the treatment that's best for you.

Get Started Today

Key Research

Ross’s clinical practice is influenced by her research in the fields of tumor biology and molecular biology. She is primarily interested in the growth factors that enable cancers such as mesothelioma to resist treatment and continue to grow, even when exposed to chemotherapeutic drugs or radiation.

Quick Fact:

Dr. Ross contributed to a case report exploring the rarely reported correlation between mesothelioma and the autoimmune disorders polymyositis.

She contributed to three studies and correlating articles about mesothelioma: a phase 3B study of treatment combinations that incorporated the drug pemetrexed; a single-arm study of pemetrexed plus cisplatin for patients with malignant pleural mesothelioma; and an extended study of pemetrexed with or without cisplatin for peritoneal mesothelioma patients.

Ross is board certified in medical oncology and hematology by the American Board of Internal Medicine. She completed a fellowship in both of these specialties at the University of California, Los Angeles after finishing her internal medicine residency at the same facility.

Although her versatility is much appreciated, her specialty of lung cancer usually dominates her time. And it shows by her work.

“Women with lung cancer now should have hope,” she said. “I have many patients with cancer who have been alive for many years after their initial diagnosis. The availability of clinical trials and the multi-disciplinary management has led to a much better quality of life.”

See More Top Mesothelioma Doctors

Dr. Helen Ross’s Publications

As a program investigator, Ross has co-authored three articles discussing results of access programs for mesothelioma. These trials have explored the combinations of pemetrexed and cisplatin (chemotherapy drugs traditionally used to treat mesothelioma) and were published in Lung Cancer, Clinical Lung Cancer and the Journal of Thoracic Oncology.

Disclaimer: Dr. Helen Ross has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Walter Pacheco, Managing Editor at
Edited by

4 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Mayo Clinic. (2010, May 19.) Women and Lung Cancer. Retrieved August 22, 2012 from Retrieved from:
  2. Mayo Clinic Cancer Center Lung Cancer Symposium. (2011, Nov. 11.) Thoracic Oncology for the Non-Oncologist. Retrieved from:
  3. Mayo Clinic School of Continuous Professional Development. (2011, Aug. 7-10.) Success With Failure: New Strategies for the Evaluation and Treatment of Congestive Heart Failure." Retrieved from:
  4. Mayo Clinic. Helen J. Ross. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified August 19, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now